NCT03071536

Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation

Furosemide Stress Test as a Marker of Postoperative Kidney Allograft Function

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 180 (estimated)
• Sponsor: King Chulalongkorn Memorial Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.

Conditions

• Kidney Function
• Kidney Transplant; Complications
• Delayed Graft Function

Interventions

Type	Name	Description
DRUG	Furosemide Injection	Furosemide 1.5 mg/kg intravenously at 3 hours post-reperfusion of kidney allograft

Timeline

• Start date: 2016-11-25
• Primary completion: 2026-05-01
• Completion: 2027-05-01
• First posted: 2017-03-07
• Last updated: 2024-01-17

Locations

1 site across 1 country: Thailand